⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6636855 | 0.74 | — | — | |
| SCHEMBL1427438 | 0.67 | — | — | |
| SCHEMBL10315584 | 0.65 | — | — | |
| SCHEMBL6779911 | 0.65 | — | — | |
| SCHEMBL1926088 | 0.62 | — | — | |
| SCHEMBL7903760 | 0.62 | ALDH1A1 (0.39) | — | |
| SCHEMBL14467763 | 0.55 | — | — | |
| SCHEMBL1035336 | 0.54 | — | — | |
| SCHEMBL872865 | 0.54 | — | — | |
| SCHEMBL586833 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119874596-A | Synthetic method of alpha, beta-unsaturated gamma-lactam | 华南理工大学 | 2025-04-25 | — | — | CN | disclosed |
| WO-2023196678-A2 | 4-PHENYL-2-PYRROLIDINONES AND METHODS OF USING THEREOF | NORTH CAROLINA STATE UNIVERSITY (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023146844-A1 | NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS | UNIVERSITY OF HOUSTON SYSTEM (US) | 2023-08-03 | — | — | WO | disclosed |
| US-20230234931-A1 | NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS | UNIVERSITY OF HOUSTON SYSTEM | 2023-07-27 | — | — | US | disclosed |
| EP-3004110-B1 | PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | NOVARTIS AG (CH) | 2017-07-26 | — | — | EP | disclosed |
| EP-3004110-A1 | PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | Novartis AG (CH) | 2016-04-13 | — | — | EP | disclosed |
| US-20160095843-A1 | PYRAZOLOPYRROLIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE | NOVARTIS AG (CH) | 2016-04-07 | — | — | US | disclosed |
| EP-2686313-B1 | BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF GLUTAMINYL CYCLASE | PROBIODRUG AG (DE) | 2016-02-03 | — | — | EP | disclosed |
| CN-102791704-B | The heterocycle inhibitor of glutaminyl cyclase (QC, EC 2.3.2.5) | PROBIODRUG AG (DE) | 2015-11-25 | — | — | CN | disclosed |
| EP-2545047-B9 | HETEROCYCLIC INHIBITORS OF GLUTAMINYL CYCLASE (QC, EC 2.3.2.5) | PROBIODRUG AG (DE) | 2015-06-10 | — | — | EP | disclosed |
| US-20120283259-A1 | NOVEL INHIBITORS | PROBIODRUG AG (DE) | 2012-11-08 | — | — | US | disclosed |
| US-8269019-B2 | Inhibitors | PROBIODRUG AG (DE) | 2012-09-18 | — | — | US | disclosed |
| WO-2011110613-A1 | HETEROCYCLIC INHIBITORS OF GLUTAMINYL CYCLASE (QC, EC 2.3.2.5) | PROBIODRUG AG (DE) | 2011-09-15 | — | — | WO | disclosed |
| US-20110224254-A1 | NOVEL INHIBITORS | PROBIODRUG AG (DE) | 2011-09-15 | — | — | US | disclosed |
| US-6936633-B2 | Pyrrolidinone derivatives | UCB S.A. (BE) | 2005-08-30 | — | — | US | disclosed |
| US-20050004180-A1 | Pyrrolidinone derivatives | USB S.A. (BE) | 2005-01-06 | — | — | US | disclosed |
| US-6727275-B2 | ANTIINFLAMMATORY, ANTIALLERGEN, AND ANTIASTHMATIC AGENTS | UCB, S.A./N.V. (BE) | 2004-04-27 | — | — | US | disclosed |
| US-4231933-A | Novel 3-hydroxy-pyrrolin-2-one derivatives | WARNER-LAMBERT COMPANY (US) | 1980-11-04 | — | — | US | disclosed |
| US-4231933-A | Novel 3-hydroxy-pyrrolin-2-one derivatives | WARNER-LAMBERT COMPANY (US) | 1980-11-04 | — | — | US | disclosed |
| US-4231933-A | Novel 3-hydroxy-pyrrolin-2-one derivatives | WARNER-LAMBERT COMPANY (US) | 1980-11-04 | — | — | US | disclosed |